Anemia News and Research

RSS
Anemia is a decrease in normal number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. However, it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few.
Medicare officials signal no payment changes on anemia drugs

Medicare officials signal no payment changes on anemia drugs

Alnylam to defend against Tekmira complaint

Alnylam to defend against Tekmira complaint

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

Global settlement agreement reached in Tuschl patents litigation

Global settlement agreement reached in Tuschl patents litigation

Extra intake of iron may not benefit pregnant women, except when anemic

Extra intake of iron may not benefit pregnant women, except when anemic

Synta fourth-quarter total collaboration revenue decreases to $3.0 million

Synta fourth-quarter total collaboration revenue decreases to $3.0 million

Iron deficiency during pregnancy may directly impact infant breathing health

Iron deficiency during pregnancy may directly impact infant breathing health

Vertex to present telaprevir and VX-222 study results against hepatitis C at EASL annual meeting

Vertex to present telaprevir and VX-222 study results against hepatitis C at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

Fresenius Medical Care announces acquisition of Hema Metrics assets related to Crit-Line system

URMC research confirms possible use of mifepristone for painful fibroids

URMC research confirms possible use of mifepristone for painful fibroids

UTHealth study: Children with H. pylori infection have lower levels of iron

UTHealth study: Children with H. pylori infection have lower levels of iron

FDA approves change to prescribing information for Gilead Sciences' Letairis

FDA approves change to prescribing information for Gilead Sciences' Letairis

Dentists need to take a closer look at potential hazards of exposing patients to zinc

Dentists need to take a closer look at potential hazards of exposing patients to zinc

Allos reaches SPA agreement with FDA for FOLOTYN Phase 3 trial in PTCL

Allos reaches SPA agreement with FDA for FOLOTYN Phase 3 trial in PTCL

VICC introduces nation's first personalized cancer decision support tool

VICC introduces nation's first personalized cancer decision support tool

Rockwell Medical fourth quarter net loss increases to $1.7 million

Rockwell Medical fourth quarter net loss increases to $1.7 million

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

International consortium of researchers genetically characterise Spanish Fanconi anaemia patients

Mathematical model predicts lifespan of stem cells

Mathematical model predicts lifespan of stem cells

Scientists discover lead contamination in ceramic cookware sold in Philadelphia's Chinatown

Scientists discover lead contamination in ceramic cookware sold in Philadelphia's Chinatown

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.